Experimental Alzheimer's drug Solanezumab fails in large trial 0 24.11.2016 17:43 United Press International (UPI.com) Ed AdamczykINDIANAPOLIS, Nov. 24 (UPI) -- Solanezumab, a promising experimental drug to treat Alzheimer's disease, failed in large trials, the Eli Lilly pharmaceutical company said. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
